Close Menu

NEW YORK (GenomeWeb News) – Investment bank Leerink Swann has raised its valuations on the stocks of Illumina and Life Technologies, citing the benefit of upcoming stimulus funding and expected gains in the next-generation sequencing market.

Analyst Isaac Ro upped his valuation on Illumina's stock to $48-$55 from his previous range of $37-$41. While he slightly lowered his revenue estimate for fiscal-year 2009 to $718.2 million from $718.6 million, he raised his estimate for FY 2010 to $920 million from $896.2 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers trace DNA on a clay pipe found at a former slave site to a population that lives in what is now Sierra Leone, the Washington Post reports.

Two researchers report on their genetic analysis of samples from a shawl thought to belong to a victim of Jack the Ripper, ScienceInsider reports.

Japan is to release rules governing some gene-edited food, according to NHK World.

In PLOS this week: computational strategy for improving gene set analysis testing, miRNAs linked to sleep apnea, and more.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.